Literature DB >> 8644864

Tissue distribution of the multidrug resistance protein.

M J Flens1, G J Zaman, P van der Valk, M A Izquierdo, A B Schroeijers, G L Scheffer, P van der Groep, M de Haas, C J Meijer, R J Scheper.   

Abstract

The human multidrug resistance protein (MRP) is a 190 kd membrane glycoprotein that can cause resistance of human tumor cells to various anticancer drugs, by extruding these drugs out of the cell. Three different monoclonal antibodies, directed against different domains of MRP, allowed us to determine the localization of MRP in a panel of normal human tissues and malignant tumors. Whereas in malignant tumors strong plasma membrane MRP staining was frequently observed, in normal human tissues MRP staining was predominantly cytoplasmatic. Here, MRP was detected in several types of epithelia, muscle cells, and macrophages. From the presence of MRP in many epithelia we infer that MRP, like MDR1 P-glycoprotein, may have an excretory function in protecting the organism against xenobiotics. Recent studies indicate a role for MRP as a carrier for transport of glutathione-conjugated endo- and xenobiotics. The presence of MRP in bronchiolar epithelium, heart muscle, and macrophages would agree with the glutathione S-conjugate carrier activity previously detected in these cells. Furthermore, in 46 of 119 untreated tumors from various histogenetic origins MRP staining was seen. In these tumors MRP may contribute to the intrinsic resistance against treatment with chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8644864      PMCID: PMC1861521     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule.

Authors:  P van der Valk; C K van Kalken; H Ketelaars; H J Broxterman; G Scheffer; C M Kuiper; T Tsuruo; J Lankelma; C J Meijer; H M Pinedo
Journal:  Ann Oncol       Date:  1990       Impact factor: 32.976

2.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

3.  Expression pattern of MRP in human tissues and adult solid tumor cell lines.

Authors:  G D Kruh; K T Gaughan; A Godwin; A Chan
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

Review 4.  ATP-dependent transport systems for organic anions.

Authors:  P Zimniak; Y C Awasthi
Journal:  Hepatology       Date:  1993-02       Impact factor: 17.425

5.  The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.

Authors:  N Krishnamachary; M S Center
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

6.  P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.

Authors:  T M Grogan; C M Spier; S E Salmon; M Matzner; J Rybski; R S Weinstein; R J Scheper; W S Dalton
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

7.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.

Authors:  M J Flens; M A Izquierdo; G L Scheffer; J M Fritz; C J Meijer; R J Scheper; G J Zaman
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

8.  Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.

Authors:  K Nooter; A M Westerman; M J Flens; G J Zaman; R J Scheper; K E van Wingerden; H Burger; R Oostrum; T Boersma; P Sonneveld
Journal:  Clin Cancer Res       Date:  1995-11       Impact factor: 12.531

9.  Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein.

Authors:  S Awasthi; S S Singhal; S K Srivastava; P Zimniak; K K Bajpai; M Saxena; R Sharma; S A Ziller; E P Frenkel; S V Singh
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.

Authors:  E Schneider; K H Cowan; H Bader; S Toomey; G N Schwartz; J E Karp; P J Burke; S H Kaufmann
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

View more
  87 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1.

Authors:  R Tommasini; R Evers; E Vogt; C Mornet; G J Zaman; A H Schinkel; P Borst; E Martinoia
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymes.

Authors:  Jeffrey C Sivils; Iven Gonzalez; Lisa J Bain
Journal:  Gen Comp Endocrinol       Date:  2010-02-21       Impact factor: 2.822

4.  Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.

Authors:  M A Izquierdo; G L Scheffer; A B Schroeijers; M C de Jong; R J Scheper
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin.

Authors:  Sarah J Hemauer; Svetlana L Patrikeeva; Tatiana N Nanovskaya; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Am J Obstet Gynecol       Date:  2010-04       Impact factor: 8.661

6.  Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.

Authors:  A B Schroeijers; G L Scheffer; M J Flens; G A Meijer; M A Izquierdo; P van der Valk; R J Scheper
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

7.  Mrp1 localization and function in cardiac mitochondria after doxorubicin.

Authors:  Paiboon Jungsuwadee; Ramaneeya Nithipongvanitch; Yumin Chen; Terry D Oberley; D Allan Butterfield; Daret K St Clair; Mary Vore
Journal:  Mol Pharmacol       Date:  2009-02-20       Impact factor: 4.436

8.  Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

Authors:  Hai Wang; Xiao-Ping Chen; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

9.  Expression and significance of angiopoietin-2 in gastric cancer.

Authors:  Xiao-Dong Sun; Xing-E Liu; Jin-Min Wu; Xiu-Jun Cai; Yi-Ping Mou; Jun-Da Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 10.  An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.